ArticleFrontiers in immunology2023

Optimal combination of MYCN differential gene and cellular senescence gene predicts adverse outcomes in patients with neuroblastoma.

Jiaxiong Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.